NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy.
about
From Inflammation to Prostate Cancer: The Role of InflammasomesThe Nucleotide Oligomerization Domain-Like Receptors in Kidney InjuryAcute and chronic kidney injury in nephrolithiasisNephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney diseaseCytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosisChronic Nephropathy from Dietary Hyperoxaluria: Sustained Improvement of Renal Function after Dietary InterventionOxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice.An animal model of type A cystinuria due to spontaneous mutation in 129S2/SvPasCrl mice.Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall's plaque.The emerging role of the inflammasome in kidney diseasesClinical utility of chitotriosidase enzyme activity in nephropathic cystinosis.Activation of the NLRP3 inflammasome in association with calcium oxalate crystal induced reactive oxygen species in kidneys.An update on the role of the inflammasomes in the pathogenesis of kidney diseases.Impact of nephrolithiasis on kidney function.Kidney Disease in Adenine Phosphoribosyltransferase Deficiency.A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I.Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis.Dendritic Cells and Macrophages: Sentinels in the Kidney.Enteric hyperoxaluria: an important cause of end-stage kidney disease.The NLRP3 inflammasome in kidney disease and autoimmunity.The in vivo evidence for regulated necrosis.Inflammasomes in the urinary tract: a disease-based review.Oxalate, inflammasome, and progression of kidney diseaseLoss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate Secretion.Genetic, pathophysiological, and clinical aspects of nephrocalcinosis.Crystal nephropathies: mechanisms of crystal-induced kidney injury.Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone Disease.Oolong tea: A critical review of processing methods, chemical composition, health effects, and risk.NLRP3 Localizes to the Tubular Epithelium in Human Kidney and Correlates With Outcome in IgA NephropathyCharacterization of calcium oxalate crystal-induced changes in the secretome of U937 human monocytes.Sodium glucose transporter-2 inhibition has no renoprotective effects on non-diabetic chronic kidney disease.siRNA Therapeutics for Primary Hyperoxaluria: A Beginning.Is the inflammasome a potential therapeutic target in renal disease?Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics.Long non-coding RNA CHCHD4P4 promotes epithelial-mesenchymal transition and inhibits cell proliferation in calcium oxalate-induced kidney damage.Summary of ISN Forefronts Symposium 2015: ‘Immunomodulation of Cardio-Renal Function’.Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal Disease.Anticancer Drug-Induced Acute Kidney Injury.IL-1 Inhibition and Vascular Function in CKD.Glycine Amidinotransferase (GATM), Renal Fanconi Syndrome, and Kidney Failure.
P2860
Q26739947-439E75A9-23C2-4CFB-A24C-916AD7440716Q26740429-4A5FD3F5-E4C7-46D2-AE89-9491B6C2F8FAQ26827230-74274F63-D0E6-46EF-AB72-CB262E8C4481Q26865804-E8E2C2A2-AFE4-4CC0-97BA-63A44D368574Q27335987-17B623E0-C49B-48E8-9A00-FF6AE60551D5Q33585896-607E3DE2-3902-4115-A9E9-687D834B0197Q33891513-7115AF01-28FA-40E3-9B89-00E5060CBBCBQ33927702-53EAA600-25A1-4A06-AE31-69F02B97059FQ34292839-6B5DFF2A-CE98-4437-ACF7-9C8A4A3AE688Q34307043-52EEB60C-A9D8-44B9-AEE5-E3AAA6D4DAEDQ34721833-105C94DA-7D8E-4A99-91EB-D02C8267ACCDQ35528594-0010715A-7EA6-4952-B1E4-1EFD6079F1DDQ35692937-ED4EDF75-6E5E-483D-B06E-330672021739Q35758325-38E60387-9DFB-4320-9FAF-262F67AE281EQ36762992-E5DED71E-31AE-45E1-849C-BC837405446EQ37439745-49F89657-F7F5-44F7-8BD2-C3748277BC77Q38206875-EC407D9B-1449-4F77-B606-895F40C383FFQ38310937-A2078A42-EF76-44D3-AD61-B07245EB35BDQ38363406-7A5060A7-15A5-4B81-9698-BF6CA929D9A2Q38787339-AB8962FF-2E45-44CA-91DB-719B5351E414Q38809791-6EB65A5E-FE83-403A-8F09-84BC3056AC4FQ38832656-8A0B88A9-915A-477F-89AC-4EFDE5E6D779Q38837256-25727183-671A-48E9-950A-86AC954A6DC4Q38851904-39530610-3722-41D9-9537-5F38AE000361Q38949044-C1F6AD52-7273-4F73-9195-C1DC2E845F1BQ39144172-9C33DA36-3591-437E-ABE5-6B739B5CE0C5Q39405553-7FCE8C88-57D7-4351-BBE1-5F782022210BQ39415415-A1CC42FF-8270-4E2E-99B4-A335D949C8A9Q39839285-6780A8BA-2929-4273-BF4F-239D5003AC68Q40112363-5028252C-B47A-4B0D-8672-F0B314C92DC2Q41814998-B2549B70-E72E-41D1-BFFD-26AFC4F7674AQ41840275-A47C52AA-FDCC-473C-9352-A0D9BD25CBBDQ41934684-BBE8601E-F43C-4B01-9764-27F80DB12F88Q41996768-3548B192-F46F-4101-BAA3-E46EE9DA71D3Q46405828-9C43935E-CD23-443E-858D-EBC1D83C5DE2Q47118419-A5C57DA9-5648-4445-8E08-33C7A9533436Q47150470-9223DA2A-1D5B-482E-B2EE-66A5071896EEQ47261056-6B8BFDAB-FA69-434A-98E0-A71922669375Q48040831-30C5E138-46B9-44A0-963F-D359E4074DBBQ52589122-A1953703-CC46-463C-B0B3-0D6CADDA3322
P2860
NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NALP3-mediated inflammation is ...... ailure in oxalate nephropathy.
@en
NALP3-mediated inflammation is ...... ailure in oxalate nephropathy.
@nl
type
label
NALP3-mediated inflammation is ...... ailure in oxalate nephropathy.
@en
NALP3-mediated inflammation is ...... ailure in oxalate nephropathy.
@nl
prefLabel
NALP3-mediated inflammation is ...... ailure in oxalate nephropathy.
@en
NALP3-mediated inflammation is ...... ailure in oxalate nephropathy.
@nl
P2093
P2860
P356
P1433
P1476
NALP3-mediated inflammation is ...... ailure in oxalate nephropathy.
@en
P2093
Felix Knauf
Gilbert W Moeckel
Ignacio Granja
Insa M Schmidt
John R Asplin
Peter S Aronson
Rachel J David
Richard A Flavell
P2860
P2888
P304
P356
10.1038/KI.2013.207
P407
P577
2013-06-05T00:00:00Z
P5875
P6179
1010733973